Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Mason

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
European Urology|August 2, 2017
Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and CompetitionAjay Aggarwal, Daniel Lewis, Susan C Charman, et al.
Vaccine|March 10, 2005
Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesotheliomaBharat Jasani, Sharon Coleman, Eric Butchart, et al.
Anticancer Research|March 16, 2016
Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient SurvivalLucy K Satherley, Ping-Hui Sun, K E Ji, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based StudyAjay Aggarwal, Daniel Lewis, Arunan Sujenthiran, et al.
European Urology Focus|October 22, 2016
Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate CancerAnnabelle South, Wendy R Parulekar, Matthew R Sydes, et al.
Journal of Medicinal Chemistry|January 30, 2014
Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical developmentMagdalena Slusarczyk, Monica Huerta Lopez, Jan Balzarini, et al.
British Journal of Cancer|November 29, 2023
Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and againstPeter Elwood, Gareth Morgan, John Watkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
The sword of Damocles and the treatment of stage I seminomaTim Oliver, Graham Mead, Malcolm Mason, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2014
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programmeAxel Heidenreich, Sergio Bracarda, Malcolm Mason, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2020
Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative explorationLauren Matheson, Jo Nayoan, Carol Rivas, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
European Urology|August 2, 2017
Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and CompetitionAjay Aggarwal, Daniel Lewis, Susan C Charman, et al.
Vaccine|March 10, 2005
Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesotheliomaBharat Jasani, Sharon Coleman, Eric Butchart, et al.
Anticancer Research|March 16, 2016
Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient SurvivalLucy K Satherley, Ping-Hui Sun, K E Ji, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based StudyAjay Aggarwal, Daniel Lewis, Arunan Sujenthiran, et al.
European Urology Focus|October 22, 2016
Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate CancerAnnabelle South, Wendy R Parulekar, Matthew R Sydes, et al.
Journal of Medicinal Chemistry|January 30, 2014
Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical developmentMagdalena Slusarczyk, Monica Huerta Lopez, Jan Balzarini, et al.
British Journal of Cancer|November 29, 2023
Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and againstPeter Elwood, Gareth Morgan, John Watkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
The sword of Damocles and the treatment of stage I seminomaTim Oliver, Graham Mead, Malcolm Mason, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2014
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programmeAxel Heidenreich, Sergio Bracarda, Malcolm Mason, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2020
Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative explorationLauren Matheson, Jo Nayoan, Carol Rivas, et al.
Pageof 8